Ma D, Dai LJ, Wu XR, Liu CL, et al. Spatial determinants of antibody-drug conjugate SHR-A1811 efficacy in neoadjuvant treatment for HER2-positive breast cancer. Cancer Cell 2025 Apr 4:S1535-6108(25)00118-7. doi: 10.1016/j.ccell.2025.
PMID: 40215979